Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE have?
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE has 265 citations in the OpenAlex counts ScholarIQ stores.
When was Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE published?
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE has 2012 year in the ScholarIQ index.
What is the open-access status of Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE?
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE has hybrid oa status in the ScholarIQ index.
What is the DOI of Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE?
The DOI for Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE is on the source record.
What is the PMID of Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE?
The PMID for Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE is on the source record.
What is the OpenAlex record for Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE?
The OpenAlex for Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE is on the source record.